As of 2025-07-06, the Relative Valuation of Landos Biopharma Inc (LABP) is (132.30) USD. This relative valuation is based on P/E multiples. With the latest stock price at 22.93 USD, the upside of Landos Biopharma Inc based on Relative Valuation is -677.0%.
The range of the Relative Valuation is (121.68) - (137.53) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 9.9x - 17.4x | 14.4x |
| Forward P/E multiples | 15.4x - 21.9x | 19.0x |
| Fair Price | (121.68) - (137.53) | (132.30) |
| Upside | -630.7% - -699.8% | -677.0% |
| Date | P/E |